Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    In: Brain, Oxford University Press (OUP), Vol. 146, No. 9 ( 2023-09-01), p. 3719-3734
    Kurzfassung: Mechanisms of resilience against tau pathology in individuals across the Alzheimer’s disease spectrum are insufficiently understood. Longitudinal data are necessary to reveal which factors relate to preserved cognition (i.e. cognitive resilience) and brain structure (i.e. brain resilience) despite abundant tau pathology, and to clarify whether these associations are cross-sectional or longitudinal. We used a longitudinal study design to investigate the role of several demographic, biological and brain structural factors in yielding cognitive and brain resilience to tau pathology as measured with PET. In this multicentre study, we included 366 amyloid-β-positive individuals with mild cognitive impairment or Alzheimer’s disease dementia with baseline 18F-flortaucipir-PET and longitudinal cognitive assessments. A subset (n = 200) additionally underwent longitudinal structural MRI. We used linear mixed-effects models with global cognition and cortical thickness as dependent variables to investigate determinants of cognitive resilience and brain resilience, respectively. Models assessed whether age, sex, years of education, APOE-ε4 status, intracranial volume (and cortical thickness for cognitive resilience models) modified the association of tau pathology with cognitive decline or cortical thinning. We found that the association between higher baseline tau-PET levels (quantified in a temporal meta-region of interest) and rate of cognitive decline (measured with repeated Mini-Mental State Examination) was adversely modified by older age (Stβinteraction = −0.062, P = 0.032), higher education level (Stβinteraction = −0.072, P = 0.011) and higher intracranial volume (Stβinteraction = −0.07, P = 0.016). Younger age, higher education and greater cortical thickness were associated with better cognitive performance at baseline. Greater cortical thickness was furthermore associated with slower cognitive decline independent of tau burden. Higher education also modified the negative impact of tau-PET on cortical thinning, while older age was associated with higher baseline cortical thickness and slower rate of cortical thinning independent of tau. Our analyses revealed no (cross-sectional or longitudinal) associations for sex and APOE-ε4 status on cognition and cortical thickness. In this longitudinal study of clinically impaired individuals with underlying Alzheimer’s disease neuropathological changes, we identified education as the most robust determinant of both cognitive and brain resilience against tau pathology. The observed interaction with tau burden on cognitive decline suggests that education may be protective against cognitive decline and brain atrophy at lower levels of tau pathology, with a potential depletion of resilience resources with advancing pathology. Finally, we did not find major contributions of sex to brain nor cognitive resilience, suggesting that previous links between sex and resilience might be mainly driven by cross-sectional differences.
    Materialart: Online-Ressource
    ISSN: 0006-8950 , 1460-2156
    RVK:
    Sprache: Englisch
    Verlag: Oxford University Press (OUP)
    Publikationsdatum: 2023
    ZDB Id: 1474117-9
    SSG: 12
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    In: Alzheimer's & Dementia, Wiley, Vol. 19, No. S3 ( 2023-06)
    Kurzfassung: Mechanisms of resilience against tau pathology in individuals across the Alzheimer’s disease (AD) spectrum are insufficiently understood. Longitudinal data is necessary for revealing which factors contribute to maintaining cognition (cognitive resilience, CR) or preserving brain structure (brain resilience, BR) despite elevated tau, and for clarifying whether these factors provide a baseline advantage and/or moderate rates of brain structural and cognitive change. We therefore investigated whether age, sex, education, APOE‐e4 status, intracranial volume (ICV) and cortical thickness (in CR analysis) moderate the association between baseline tau load and subsequent changes in cognition and cortical thickness. Methods The study included 341 amyloid‐β‐positive individuals from a multi‐cohort dataset (BioFINDER‐1/AVID/ADNI/UCSF), diagnosed with MCI or AD dementia at the time of the baseline [ 18 F]flortaucipir tau‐PET scan, who had longitudinal cognitive assessments (CR sample). A subset (n = 133) additionally underwent longitudinal structural MRI (BR sample). We used (separate) linear mixed‐effect models with MMSE as outcome to investigate the association of key baseline variables‐of‐interest (age, sex, APOE‐e4 status, education, ICV and global cortical thickness) with cognitive decline in the presence of tau (covaried for cohort). A three‐way interaction between time, tau and the predictor‐of‐interest was initially assessed. In the absence of a moderation effect, we subsequently assessed models including only the two‐way interaction between each predictor and time. These analyses were repeated with global cortical thinning as an outcome variable. Results Characteristics of the CR sample and BR sub‐sample are described in Table‐1. Models revealed that younger age (β Interaction = ‐0.18, p 〈 0.01), higher education (β Interaction = ‐0.62, p 〈 0.001), larger ICV (β Interaction = ‐8.12, p 〈 0.01) and greater cortical thickness (β Interaction = ‐9.9, p 〈 0.05) were related to higher CR, as these factors moderated the relationship between tau pathology and decline in MMSE (Figure‐1,2). No predictor moderated tau effects on cortical thinning nor explained additional variance (Table‐2). Conclusion This study indicates that tau pathology affects cognitive decline differently across age, education, ICV and cortical thickness levels. Understanding moderators of prospective cognitive decline and cortical thinning related to tau pathology, as well as their complex interactions, may be relevant for improving prognosis and clinical trial design in AD.
    Materialart: Online-Ressource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2023
    ZDB Id: 2201940-6
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    In: Brain, Oxford University Press (OUP), Vol. 143, No. 11 ( 2020-11-01), p. 3234-3241
    Kurzfassung: Plasma levels of tau phosphorylated at threonine-217 (p-tau217) is a candidate tool to monitor Alzheimer’s disease. We studied 150 cognitively unimpaired participants and 100 patients with mild cognitive impairment in the Swedish BioFINDER study. P-tau217 was measured repeatedly for up to 6 years (median three samples per person, median time from first to last sample, 4.3 years). Preclinical (amyloid-β-positive cognitively unimpaired, n = 62) and prodromal (amyloid-β-positive mild cognitive impairment, n = 49) Alzheimer’s disease had accelerated p-tau217 compared to amyloid-β-negative cognitively unimpaired (β  =  0.56, P  & lt; 0.001, using linear mixed effects models) and amyloid-β-negative mild cognitive impairment patients (β  =  0.67, P  & lt; 0.001), respectively. Mild cognitive impairment patients who later converted to Alzheimer’s disease dementia (n = 40) had accelerated p-tau217 compared to other mild cognitive impairment patients (β  =  0.79, P  & lt; 0.001). P-tau217 did not change in amyloid-β-negative participants, or in patients with mild cognitive impairment who did not convert to Alzheimer’s disease dementia. For 80% power, 109 participants per arm were required to observe a slope reduction in amyloid-β-positive cognitively unimpaired (71 participants per arm in amyloid-β-positive mild cognitive impairment). Longitudinal increases in p-tau217 correlated with longitudinal worsening of cognition and brain atrophy. In summary, plasma p-tau217 increases during early Alzheimer’s disease and can be used to monitor disease progression.
    Materialart: Online-Ressource
    ISSN: 0006-8950 , 1460-2156
    RVK:
    Sprache: Englisch
    Verlag: Oxford University Press (OUP)
    Publikationsdatum: 2020
    ZDB Id: 1474117-9
    SSG: 12
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 4
    In: Nature Communications, Springer Science and Business Media LLC, Vol. 12, No. 1 ( 2021-06-11)
    Kurzfassung: Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma measurements of amyloid-β (Aβ)42/40, phospho-tau217 (P-tau217), and neurofilament light (NfL) together predict clinical deterioration in 435 CU individuals followed for an average of 4.8 ± 1.7 years in the BioFINDER study. A combination of all three plasma biomarkers and basic demographics best predicted change in cognition (Pre-Alzheimer’s Clinical Composite; R 2  = 0.14, 95% CI [0.12–0.17]; P  〈  0.0001) and subsequent AD dementia (AUC = 0.82, 95% CI [0.77–0.91], P  〈  0.0001). In a simulated clinical trial, a screening algorithm combining all three plasma biomarkers would reduce the required sample size by 70% (95% CI [54–81]; P  〈  0.001) with cognition as trial endpoint, and by 63% (95% CI [53–70], P  〈  0.001) with subsequent AD dementia as trial endpoint. Plasma ATN biomarkers show usefulness in cognitively unimpaired populations and could make large clinical trials more feasible and cost-effective.
    Materialart: Online-Ressource
    ISSN: 2041-1723
    Sprache: Englisch
    Verlag: Springer Science and Business Media LLC
    Publikationsdatum: 2021
    ZDB Id: 2553671-0
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 5
    In: Alzheimer's & Dementia, Wiley, Vol. 17, No. S6 ( 2021-12)
    Kurzfassung: A better understanding of drivers behind neuropsychiatric symptoms (NPS) in neurocognitive diseases, such as Alzheimer’s disease, can potentially guide drug development. Cross‐sectional studies have related apathy, depression and anxiety to beta‐amyloid‐ (Aβ) and tau‐pathology, neurodegeneration as well as cognitive deficits already at preclinical stages. However, longitudinal studies are scarce and often small. We investigated effects of neuropathology and cognition on the longitudinal trajectories of NPS in a large group of cognitively unimpaired subjects (CU). Method The sample originated from the Swedish BioFINDER study. CU subjects with at least one NPS assessment during the biennial follow‐up of maximum 8 years were included (n=356). The Apathy Evaluation Scale (AES) and the Hospital Depression and Anxiety Scale (HADS) assessed apathy as well as anxious and depressive symptoms, respectively. The Mini Mental State Examination (MMSE) and a modified Preclinical Alzheimer Cognitive Composite (mPACC) measured cognition longitudinally. Plasma P‐tau 217 , CSF Aβ42/Aβ40 ratio and CSF neurofilament light (NfL) were quantified at baseline using immunoassays. Magnetic Resonance Imaging quantified white matter lesions (WML). Subject‐specific cognitive change per year (slope) was obtained by linear regression models. Linear mixed effect models were used to test associations between longitudinal NPS and other measures (including longitudinal cognition). Results Subjects with lower levels of CSF Aβ42/40 (β=‐0.060, p=0.01) or higher plasma P‐tau 217 (β=0.253, p=0.015) at study start demonstrated accelerated levels of apathy over time. On a trend level, a high load of WML predicted over time high levels of apathy (β=0.183, p=0.053). Increased levels of longitudinal anxiety were predicted by the interaction between time and lower CSF Aβ42/40 (β=‐0.283, p=0.005) or higher CSF NfL (β=0.054, p=0.024). Furthermore, more rapid decline in mPACC was associated with more rapid progression of apathy (β=‐0.478, p= 〈 0.001) and anxiety (β=‐0.066, p= 〈 0.023). Similar results were obtained for longitudinal associations between MMSE and apathy (β=‐0.673, p= 〈 0.001). Conclusion These results suggests that the longitudinal trajectories of apathy and anxiety already in CU subjects are related to key hallmarks of Alzheimer´s disease, including Aβ‐ or tau‐pathology at baseline, and further are parallel with cognitive decline over time.
    Materialart: Online-Ressource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2021
    ZDB Id: 2201940-6
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 6
    In: Alzheimer's & Dementia, Wiley, Vol. 17, No. S6 ( 2021-12)
    Kurzfassung: Cognitive resilience refers to processes involved in coping with effects of brain pathology on cognition. Factors contributing to cognitive resilience against brain atrophy are unclear, as there have been few longitudinal studies investigating this. Therefore we aimed to identify factors explaining the discrepancy between brain atrophy and longitudinal cognitive decline. One proposed method of investigating cognitive resilience is a residual approach, which suggests using the variance in cognition not explained by a specified predictor as a measure of resilience. Method Cognitively unimpaired subjects (n=406) from The Swedish BioFINDER Study with magnetic resonance imaging (MRI) and cognitive test results from at least two time points were included. Using FreeSurfer, global cortical thickness was calculated. A cognitive composite score was calculated from Mini Mental State Examination, Alzheimer´s Disease Assessment Scale – Cognitive Subscale delayed word recall, Trail Making Test B, and Animal fluency. For each subject, the beta coefficients for change in cortical thickness and change in cognition over time were calculated. Linear regression was performed between the two beta coefficients, and the residuals were used as a measure of cognitive resilience. Associations were calculated between this resilience measure and baseline demographics, biomarkers of amyloid (cerebrospinal fluid (CSF) β‐amyloid (Aβ) 42/40 ratio), tau (CSF phosphorylated tau (p‐tau)), and vascular (MRI white matter lesion (WML) volume) pathology as well as neurodegeneration (CSF neurofilament light (NfL)). For dichotomous variables (sex and pathologic Aβ42/40 ratio) independent samples t‐tests, and for continuous variables (all other variables) Pearson correlations, were performed. Result In univariate models, lower age at baseline, female sex, higher cortical thickness and better cognitive results at baseline were associated with higher cognitive resilience against cortical atrophy, while education was not. Further, pathological Aβ42/40 ratio and higher levels of p‐tau, NfL, and WMLs at baseline were negatively associated with cognitive resilience in univariate analyses. In a multivariable linear regression model, lower baseline cortical thickness, a pathological Aβ42/40 ratio, and higher NfL were significantly associated with worse cognitive resilience (Figure 1, Table 1). Conclusion Markers of Alzheimer´s disease pathology and neurodegeneration are associated with worse than expected cognitive decline at a given rate of brain atrophy.
    Materialart: Online-Ressource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Sprache: Englisch
    Verlag: Wiley
    Publikationsdatum: 2021
    ZDB Id: 2201940-6
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 7
    In: The Lancet Neurology, Elsevier BV, Vol. 19, No. 4 ( 2020-04), p. 307-316
    Materialart: Online-Ressource
    ISSN: 1474-4422
    Sprache: Englisch
    Verlag: Elsevier BV
    Publikationsdatum: 2020
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz